$43.790
+4.147 (+9.47%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
GMAB 相似图表分析预测
Alphio's GMAB stock price prediction model matches the current Genmab A/S tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $43.93 (+0.33%). The 1-week path is $43.75 (-0.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Genmab A/S 股票吗？
Genmab A/S (GMAB) is a good buy right now due to its current price of $37, which is significantly below the average analyst price target of $50, indicating a potential upside of 35%. Additionally, the company has demonstrated strong financial performance with a gross margin of 92.73% in Q2 2026, showcasing its efficiency and profitability. However, the main risk is the recent failure of the Epcoritamab trial, which could impact future sales expectations and market acceptance.
GMAB 股价于 Friday 收于 $43.79，此前上涨 +9.47%
Genmab A/S (GMAB) last closed at $43.79, gaining +9.47%. These facts feed the 1-day and 1-week GMAB price prediction above.
预测驱动因素
Genmab A/S（GMAB）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似图表形态
近期走势与 GMAB 最接近的股票，按相似度排序。
GMAB 季节性分析
Historically the probability of a positive October return for GMAB is 63.49%. September offers the highest probability of a positive month at 67.74%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
GMAB 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Oct 2026 | $17.30 | $21.62 | $22.57 | -50.62% |
| Nov 2026 | $28.07 | $28.69 | $33.47 | -34.48% |
| Dec 2026 | $24.17 | $24.45 | $26.55 | -44.17% |
2026 年，Genmab A/S（GMAB）预计区间为 $17.30 至 $33.47。
Genmab A/S 2026 年月度预测
2026 年 Oct，Genmab A/S 预计均价 $21.62，最低 $17.30，最高 $22.57。
2026 年 Nov，Genmab A/S 预计均价 $28.69，最低 $28.07，最高 $33.47。
2026 年 Dec，Genmab A/S 预计均价 $24.45，最低 $24.17，最高 $26.55。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。